FDA fast tracks epcoritamab for follicular lymphoma

COPENHAGEN - The U.S. Food and Drug Administration (FDA) has granted Priority Review for epcoritamab, a potential new treatment for patients with relapsed or refractory follicular lymphoma, announced Genmab A/S (NASDAQ: NASDAQ:GMAB) and AbbVie (NYSE: NYSE:ABBV). This designation could significantly expedite the therapy\'s approval process, with a target action date set for June 28, 2024....

Read More

Australia\'s Coles denies price gouging, says food inflation is a global problem

By Byron Kaye and Echha Jain SYDNEY (Reuters) - Australia\'s No. 2 supermarket operator Coles Group (OTC:CLEGF) on Tuesday rejected accusations of price gouging as its first-half profit beat analyst forecasts, saying food inflation was a global problem and its margins were steady. Coles and larger rival Woolworths Group, which together account for two-thirds of...

Read More

Bitcoin breaks $57,000 as big buyers circle

SINGAPORE (Reuters) - Cryptocurrency bitcoin hit a two-year high above $57,000 in Asia trade on Tuesday on signs of heavy institutional buying, while smaller rival ether topped $3,200 for the first time in two years. Bitcoin has rallied more than 10% in two sessions, helped by a Monday disclosure from crypto investor and software firm...

Read More

Ant Group outbids Citadel for Credit Suisse\'s China unit, Bloomberg reports

(Reuters) -Fintech giant Ant Group has outbid billionaire Ken Griffin\'s Citadel Securities for Credit Suisse\'s investment bank venture in China, Bloomberg News reported on Sunday, adding it was unclear whether the Chinese company\'s offer would succeed. Alibaba (NYSE:BABA) Group affiliate Ant Group\'s bid to build a securities business in China using Credit Suisse\'s operations would...

Read More